Csenge Advisory Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Csenge Advisory Group’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,621	Closed	-$209K	–	649
2022 Q1	$209K	Buy	+2,621	New	+$203K	0.02%	595
2018 Q4	–	Sell	-7	Closed	–	–	1129
2018 Q3	$0	Buy	+7	New	+$502	﹤0.01%	1462

Other funds holding PJP

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

DBIA

Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return

Csenge Advisory Group's PJP Position: Q2 2022 in Review

Csenge Advisory Group sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2022, closing a stake of 2,621 shares — an estimated $209K sold.

Csenge Advisory Group first reported a position in PJP in Q3 2018 and held it in 2 quarters. The position peaked at $209K in Q1 2022. 79 funds tracked by Wall St. Rank hold PJP as of Q2 2022.

Csenge Advisory Group reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2022 after selling out during the quarter.
Csenge Advisory Group sold 2,621 Invesco Pharmaceuticals ETF shares in Q2 2022, an estimated $209K.
Csenge Advisory Group first reported a position in Invesco Pharmaceuticals ETF in Q3 2018 and held it in 2 quarters.
Csenge Advisory Group's Invesco Pharmaceuticals ETF position peaked at $209K in Q1 2022.
79 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2022.

Based on Csenge Advisory Group's 13F filing for Q2 2022, filed 27 Jul 2022.